![](https://rakesh-jhunjhunwala.in/wp-content/uploads/2014/04/images-150x1501-100x100.jpg)
IndiaNivesh has issued an ‘Initiating Coverage’ report on Indoco Remedies claiming that the Company can deliver 46% CAGR earnings over FY14-17E and that there is huge upside from the stock
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments